Of these, IGFBP-1 has been consistently shown to be inversely associated with overweight and obesity (16–18), plasma insulin and glucose levels (19, 20), as well as fasting plasma leptin levels (21). Here, IGFBP1 is linked to obesity due to melanocortin 4 receptor deficiency.